Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · IEX Real-Time Price · USD
0.00 (0.00%)
Apr 23, 2024, 11:04 AM EDT - Market open

Alpha Tau Medical Statistics

Total Valuation

DRTS has a market cap or net worth of $170.00 million. The enterprise value is $101.48 million.

Market Cap 170.00M
Enterprise Value 101.48M

Important Dates

The next estimated earnings date is Tuesday, May 21, 2024, after market close.

Earnings Date May 21, 2024
Ex-Dividend Date n/a

Share Statistics

DRTS has 69.67 million shares outstanding. The number of shares has increased by 9.20% in one year.

Shares Outstanding 69.67M
Shares Change (YoY) +9.20%
Shares Change (QoQ) +0.21%
Owned by Insiders (%) 25.72%
Owned by Institutions (%) 2.74%
Float 51.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.01
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.08, with a Debt / Equity ratio of 0.16.

Current Ratio 12.08
Quick Ratio n/a
Debt / Equity 0.16
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3.46

Financial Efficiency

Return on equity (ROE) is -31.90% and return on invested capital (ROIC) is -36.50%.

Return on Equity (ROE) -31.90%
Return on Assets (ROA) -26.40%
Return on Capital (ROIC) -36.50%
Revenue Per Employee n/a
Profits Per Employee -$240,967
Employee Count 121
Asset Turnover n/a
Inventory Turnover n/a


In the past 12 months, DRTS has paid $16,000 in taxes.

Income Tax 16,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.78% in the last 52 weeks. The beta is 0.71, so DRTS's price volatility has been lower than the market average.

Beta (1Y) 0.71
52-Week Price Change -20.78%
50-Day Moving Average 2.94
200-Day Moving Average 3.27
Relative Strength Index (RSI) 19.25
Average Volume (30 Days) 32,237

Short Selling Information

The latest short interest is 56,504, so 0.08% of the outstanding shares have been sold short.

Short Interest 56,504
Short Previous Month 34,885
Short % of Shares Out 0.08%
Short % of Float 0.11%
Short Ratio (days to cover) 2.17

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -35.68M
Pretax Income -29.14M
Net Income -29.16M
EBITDA -21.53M
EBIT -22.60M
Earnings Per Share (EPS) -$0.42
Full Income Statement

Balance Sheet

The company has $81.79 million in cash and $13.28 million in debt, giving a net cash position of $68.51 million or $0.98 per share.

Cash & Cash Equivalents 81.79M
Total Debt 13.28M
Net Cash 68.51M
Net Cash Per Share $0.98
Equity / Book Value 84.48M
Book Value Per Share 1.21
Working Capital 78.65M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$17.96 million and capital expenditures -$6.40 million, giving a free cash flow of -$24.36 million.

Operating Cash Flow -17.96M
Capital Expenditures -6.40M
Free Cash Flow -24.36M
FCF Per Share -$0.35
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DRTS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.20%
Shareholder Yield -9.20%
Earnings Yield -17.15%
FCF Yield -14.33%

Analyst Forecast

The average price target for DRTS is $11.75, which is 381.56% higher than the current price. The consensus rating is "Strong Buy".

Price Target $11.75
Price Target Difference 381.56%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 1